Alkermes
agents that induce immunogenic cell death may offer synergistic advantages in combination with chemotherapy or radiation agents that induce immunogenic cell death include immune inhibitors growth factor pathway inhibitors cytotoxic chemotherapies radiation activated cancer fighting cells pharmacotherapy | Alkermes
Company
Deck Type
Deck date
March 2021
Slide
90 of 144
Similar slides by Alkermes
Investor Day
March 2021
Investor Day
March 2021
Related slides by other companies
Investor Presentation
October 2022
SPAC
October 2021
Investor Presentation
July 2023
IPO
March 2024
Other recent decks by Alkermes
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io